The German health insurance system is not as cost-effective as in some of Germany's neighbouring countries, which, given present expenditure levels, indicates a need to improve efficiency and value for patients.
We designed the study to be descriptive only and present unadjusted expenditures.
Tables 2, 3, 4 and 5 present the expenditures per DDD (total, TPP, patient out-of-pocket) and the number of patients in our sample treated by each molecule.
In the present study expenditures, outputs and costs are analysed for the Maputo Central Hospital and its Special Clinic with the objective of identifying net resource flows between a system operating two-tier charging, and, ultimately, understanding whether public hospitals can somehow benefit from running Special Clinic operations.
At present, medical expenditure is increasing dramatically everywhere in the world.
Older diabetic individuals presented higher expenditures on medication for the treatment of diseases other than T2DM.
In addition, in the present study expenditure on laboratory services and imaging were not increased prior to diagnosis.
Diabetic individuals aged over 50 years presented higher expenditures on medication for the treatment of diseases other than T2DM (p = 0.041).
As a result of reduced incidence of ketoacidosis in the present cohort, expenditure on ketoacidosis admissions was decreased by 64%; thus, the potential for cost saving across the UK is considerable.
Table 2 presents predicted expenditures, based on our regression models, for an average child who does or does not have a smoker in the house, comparing our estimates from the unadjusted model to the model where we adjust for potential confounders.
